Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Edwards Lifesciences Corporation EW

Full chart Compare
Set alert

Price alert · EW

All alert types
95.19 USD +1.93 (+2.07%)

At closeNov 3, 2026, 6:40 PM EST

95.19 0.00 0.00%

After hours · Nov 3, 6:40 PM ET

93.27 Day range 96.09
74.66 52-week range 96.29
YTD
+11.66%
1 year
+14.59%

Financial health

Altman Z-Score

13.03 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 3
  • Return on Equity 3
  • Return on Assets 4
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E 46.3×
FY 2016: 35.1×FY 2017: 38.3×FY 2018: 44.4×FY 2019: 46.3×FY 2020: 69.1×FY 2021: 53.8×FY 2022: 30.3×FY 2023: 33.0×FY 2024: 10.6×FY 2025: 46.3×
FY 2016 5y median 33.0× FY 2025
P/S 8.2×
FY 2016: 6.7×FY 2017: 6.9×FY 2018: 8.6×FY 2019: 11.2×FY 2020: 12.9×FY 2021: 15.4×FY 2022: 8.6×FY 2023: 9.2×FY 2024: 8.1×FY 2025: 8.2×
FY 2016 5y median 8.6× FY 2025
P/B 4.8×
FY 2016: 7.6×FY 2017: 7.9×FY 2018: 10.2×FY 2019: 11.7×FY 2020: 12.4×FY 2021: 13.8×FY 2022: 8.0×FY 2023: 7.0×FY 2024: 4.4×FY 2025: 4.8×
FY 2016 5y median 7.0× FY 2025
P/FCF 37.3×
FY 2016: 41.0×FY 2017: 28.8×FY 2018: 46.8×FY 2019: 53.9×FY 2020: 87.8×FY 2021: 57.6×FY 2022: 48.4×FY 2023: 73.5×FY 2024: 153×FY 2025: 37.3×
FY 2016 5y median 57.6× FY 2025
EV/EBITDA 33.3×
FY 2016: 24.0×FY 2017: 21.0×FY 2018: 36.6×FY 2019: 37.5×FY 2020: 53.8×FY 2021: 43.3×FY 2022: 23.8×FY 2023: 29.8×FY 2024: 24.3×FY 2025: 33.3×
FY 2016 5y median 29.8× FY 2025
EV/Sales 7.8×
FY 2016: 6.7×FY 2017: 7.0×FY 2018: 8.6×FY 2019: 11.1×FY 2020: 12.8×FY 2021: 15.4×FY 2022: 8.6×FY 2023: 9.1×FY 2024: 7.7×FY 2025: 7.8×
FY 2016 5y median 8.6× FY 2025
FCF Yield 2.7%
FY 2016: 2.4%FY 2017: 3.5%FY 2018: 2.1%FY 2019: 1.9%FY 2020: 1.1%FY 2021: 1.7%FY 2022: 2.1%FY 2023: 1.4%FY 2024: 0.7%FY 2025: 2.7%
FY 2016 5y median 1.7% FY 2025

Profitability

Gross Margin 78.1%
FY 2016: 72.8%FY 2017: 74.3%FY 2018: 75.2%FY 2019: 73.4%FY 2020: 74.9%FY 2021: 76.6%FY 2022: 78.3%FY 2023: 79.3%FY 2024: 79.5%FY 2025: 78.1%
FY 2016 5y median 78.3% FY 2025
Operating Margin 27.0%
FY 2016: 27.5%FY 2017: 29.4%FY 2018: 29.3%FY 2019: 27.6%FY 2020: 29.5%FY 2021: 30.8%FY 2022: 31.6%FY 2023: 28.5%FY 2024: 25.3%FY 2025: 27.0%
FY 2016 5y median 28.5% FY 2025
Net Margin 17.7%
FY 2016: 19.2%FY 2017: 18.1%FY 2018: 19.4%FY 2019: 24.1%FY 2020: 18.8%FY 2021: 28.7%FY 2022: 28.3%FY 2023: 28.0%FY 2024: 76.7%FY 2025: 17.7%
FY 2016 5y median 28.3% FY 2025
ROE 10.4%
FY 2016: 21.7%FY 2017: 20.8%FY 2018: 23.0%FY 2019: 25.2%FY 2020: 18.0%FY 2021: 25.8%FY 2022: 26.2%FY 2023: 21.1%FY 2024: 41.8%FY 2025: 10.4%
FY 2016 5y median 25.8% FY 2025
ROIC 11.4%
FY 2016: 15.8%FY 2017: 11.6%FY 2018: 23.3%FY 2019: 19.2%FY 2020: 18.3%FY 2021: 19.0%FY 2022: 20.1%FY 2023: 15.5%FY 2024: 10.7%FY 2025: 11.4%
FY 2016 5y median 15.5% FY 2025
ROA 7.8%
FY 2016: 12.6%FY 2017: 10.9%FY 2018: 13.6%FY 2019: 16.1%FY 2020: 11.4%FY 2021: 17.7%FY 2022: 18.4%FY 2023: 15.0%FY 2024: 32.0%FY 2025: 7.8%
FY 2016 5y median 17.7% FY 2025

Growth (YoY)

Revenue 11.5%
FY 2016: 18.8%FY 2017: 15.9%FY 2018: 8.4%FY 2019: 16.8%FY 2020: 0.9%FY 2021: 19.3%FY 2022: 2.9%FY 2023: -6.9%FY 2024: 8.6%FY 2025: 11.5%
FY 2016 FY 2025
Operating Income 18.7%
FY 2016: 41.6%FY 2017: 23.9%FY 2018: 8.1%FY 2019: 9.7%FY 2020: 8.2%FY 2021: 24.3%FY 2022: 5.7%FY 2023: -16.2%FY 2024: -3.4%FY 2025: 18.7%
FY 2016 FY 2025
EPS (diluted) -73.7%
FY 2016: 16.0%FY 2017: 10.3%FY 2018: 17.7%FY 2019: 45.1%FY 2020: -20.7%FY 2021: 83.1%FY 2022: 2.5%FY 2023: -5.7%FY 2024: 203.0%FY 2025: -73.7%
FY 2016 FY 2025
Free Cash Flow 360.5%
FY 2016: 9.9%FY 2017: 69.4%FY 2018: -17.0%FY 2019: 31.5%FY 2020: -28.2%FY 2021: 116.7%FY 2022: -32.0%FY 2023: -34.0%FY 2024: -53.9%FY 2025: 360.5%
FY 2016 FY 2025

Financial Health

Current Ratio 3.7×
FY 2016: 4.2×FY 2017: 1.8×FY 2018: 2.6×FY 2019: 3.3×FY 2020: 3.5×FY 2021: 3.1×FY 2022: 3.0×FY 2023: 3.4×FY 2024: 4.2×FY 2025: 3.7×
FY 2016 5y median 3.4× FY 2025
Quick Ratio 3.1×
FY 2016: 3.5×FY 2017: 1.4×FY 2018: 1.9×FY 2019: 2.6×FY 2020: 2.6×FY 2021: 2.4×FY 2022: 2.2×FY 2023: 2.6×FY 2024: 3.5×FY 2025: 3.1×
FY 2016 5y median 2.6× FY 2025
Debt / Equity 0.1×
FY 2016: 0.3×FY 2017: 0.3×FY 2018: 0.2×FY 2019: 0.2×FY 2020: 0.2×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -1.6×
FY 2016: -0.1×FY 2017: 0.2×FY 2018: -0.1×FY 2019: -0.4×FY 2020: -0.5×FY 2021: -0.1×FY 2022: -0.0×FY 2023: -0.3×FY 2024: -1.4×FY 2025: -1.6×
FY 2016 5y median -0.3× FY 2025
Interest Coverage 0.0×
FY 2016: 45.3×FY 2017: 43.5×FY 2018: 32.7×FY 2019: 43.9×FY 2020: 58.4×FY 2021: 64.9×FY 2022: 65.0×FY 2023: 81.1×FY 2024: 69.6×FY 2025: 0.0×
FY 2016 5y median 65.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31